Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging

Hyperphosphorylation and accumulation of tau aggregates are prominent features in tauopathies, including Alzheimer's disease, but the impact of loss of tau function on synaptic and cognitive deficits remains poorly understood. We report that old (19–20 months; OKO) but not middle-aged (8–9 months; MKO) tau knock-out mice develop Morris Water Maze (MWM) deficits and loss of hippocampal acetylated α-tubulin and excitatory synaptic proteins. Mild motor deficits and reduction in tyrosine hydroxylase (TH) in the substantia nigra were present by middle age, but did not affect MWM performance, whereas OKO mice showed MWM deficits paralleling hippocampal deficits. Deletion of tau, a microtubule-associated protein (MAP), resulted in increased levels of MAP1A, MAP1B, and MAP2 in MKO, followed by loss of MAP2 and MAP1B in OKO. Hippocampal synaptic deficits in OKO mice were partially corrected with dietary supplementation with docosahexaenoic acid (DHA) and both MWM and synaptic deficits were fully corrected by combining DHA with α-lipoic acid (ALA), which also prevented TH loss. DHA or DHA/ALA restored phosphorylated and total GSK3β and attenuated hyperactivation of the tau C-Jun N-terminal kinases (JNKs) while increasing MAP1B, dephosphorylated (active) MAP2, and acetylated α-tubulin, suggesting improved microtubule stability and maintenance of active compensatory MAPs. Our results implicate the loss of MAP function in age-associated hippocampal deficits and identify a safe dietary intervention, rescuing both MAP function and TH in OKO mice. Therefore, in addition to microtubule-stabilizing therapeutic drugs, preserving or restoring compensatory MAP function may be a useful new prevention strategy.

[1]  R. Bazinet,et al.  Whole body synthesis rates of DHA from α-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats[S] , 2013, Journal of Lipid Research.

[2]  Dana Waichunas,et al.  A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease , 2013, Journal of Alzheimer's disease : JAD.

[3]  W. Harris,et al.  Long-chain omega-3 fatty acids: time to establish a dietary reference intake. , 2013, Nutrition reviews.

[4]  Meaghan Morris,et al.  Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice , 2013, Neurobiology of Aging.

[5]  E. Capetillo-Zarate,et al.  Accumulation of Intraneuronal β-Amyloid 42 Peptides Is Associated with Early Changes in Microtubule-Associated Protein 2 in Neurites and Synapses , 2013, PloS one.

[6]  A. Ittner,et al.  Lessons from Tau-Deficient Mice , 2012, International journal of Alzheimer's disease.

[7]  Blaine R. Roberts,et al.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.

[8]  F. Cicchetti,et al.  Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease , 2011, Journal of Lipid Research.

[9]  L. Packer,et al.  Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling , 2010, Journal of clinical biochemistry and nutrition.

[10]  G. Cole,et al.  Dietary fatty acids and the aging brain. , 2010, Nutrition reviews.

[11]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[12]  S. Rapoport,et al.  Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA2β (VIA)-deficient mice , 2010, Journal of Lipid Research.

[13]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[14]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[15]  B. Ames Optimal micronutrients delay mitochondrial decay and age-associated diseases , 2010, Mechanisms of Ageing and Development.

[16]  G. Garden,et al.  A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia , 2010, Journal of visualized experiments : JoVE.

[17]  Zhiyong Zhang,et al.  JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease , 2009, Journal of the Neurological Sciences.

[18]  H. Vinters,et al.  β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin , 2009, The Journal of Neuroscience.

[19]  G. Cole,et al.  GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals , 2009, Neurobiology of Disease.

[20]  R. Wade-Martins,et al.  Knock-out and transgenic mouse models of tauopathies , 2009, Neurobiology of Aging.

[21]  Shih-Yi Huang,et al.  The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  C. Cotman,et al.  Inflammatory changes parallel the early stages of Alzheimer disease , 2007, Neurobiology of Aging.

[23]  Y. von Boxberg,et al.  Extensive structural remodeling of the injured spinal cord revealed by phosphorylated MAP1B in sprouting axons and degenerating neurons , 2007, The European journal of neuroscience.

[24]  L. Buée,et al.  Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. , 2007, The American journal of pathology.

[25]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[26]  B. Riederer,et al.  Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein , 2007, Brain Research Bulletin.

[27]  G. Collingridge,et al.  LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.

[28]  T. Montine,et al.  Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice , 2007, Neurobiology of Aging.

[29]  S. Halpain,et al.  The MAP1 family of microtubule-associated proteins , 2006, Genome Biology.

[30]  R. Berry,et al.  Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[31]  B. Teter,et al.  Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro , 2006 .

[32]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[33]  Jeppe Falsig,et al.  Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway , 2005, The Journal of Neuroscience.

[34]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[35]  P. Marsh,et al.  Glycogen synthase kinase-3β phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons , 2005, Journal of Cell Science.

[36]  G. Pigino,et al.  Polyglutamine expansion diseases: failing to deliver. , 2005, Trends in molecular medicine.

[37]  Chi Li,et al.  Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Halpain,et al.  The MAP2/Tau family of microtubule-associated proteins , 2004, Genome Biology.

[39]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[40]  R. Rissman,et al.  Biochemical analysis of GABAA receptor subunits α1, α5, β1, β2 in the hippocampus of patients with Alzheimer's disease neuropathology , 2003, Neuroscience.

[41]  R. Berry,et al.  Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  George Perry,et al.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.

[43]  M. Mesulam,et al.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.

[44]  Mark Ellisman,et al.  JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. , 2003, Developmental cell.

[45]  P. Adlard,et al.  Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease , 2002, Acta Neuropathologica.

[46]  B. Ames,et al.  Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Z. Bashir,et al.  Long-term depression: a cascade of induction and expression mechanisms , 2001, Progress in Neurobiology.

[48]  N. Hirokawa,et al.  Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization , 2001, The Journal of cell biology.

[49]  S. Hossain,et al.  Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.

[50]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[51]  S. Lovestone,et al.  Neurofibrillary tangles and tau phosphorylation. , 2001, Biochemical Society symposium.

[52]  L. Martin,et al.  N-Methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease , 2001, Journal of the Neurological Sciences.

[53]  C. Kessler,et al.  Brain plasticity: to what extent do aged animals retain the capacity to coordinate gene activity in response to acute challenges , 2000, Experimental Gerontology.

[54]  N. Hirokawa,et al.  Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes , 2000, The Journal of cell biology.

[55]  N. Hirokawa,et al.  Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. , 2000, Science.

[56]  J. Ávila,et al.  Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function , 2000, Progress in Neurobiology.

[57]  W. Blackstock,et al.  Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry , 2000, Journal of neurochemistry.

[58]  J. Ávila,et al.  GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. , 2000, European journal of cell biology.

[59]  N. Hirokawa,et al.  Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice , 2000, Neuroscience Letters.

[60]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[61]  R. Goold,et al.  Glycogen synthase kinase 3 β phosphorylation of microtubule-associated protein 1 B regulates the stability of microtubules in growth cones , 1999 .

[62]  G. Jicha,et al.  A Conformation‐ and Phosphorylation‐Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease , 1997, Journal of neurochemistry.

[63]  I. Fischer,et al.  Localisation of Microtubule‐Associated Protein 1B Phosphorylation Sites Recognised by Monoclonal Antibody SMI‐31 , 1997, Journal of neurochemistry.

[64]  J. Brion,et al.  Reduction of Acetylated α-Tubulin Immunoreactivity in Neurofibrillary Tangle-bearing Neurons in Alzheimer's Disease , 1996 .

[65]  J. Brion,et al.  Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. , 1996, Journal of neuropathology and experimental neurology.

[66]  Alejandra del C. Alonso,et al.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.

[67]  K. Kosik,et al.  MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth. , 1996, Journal of cell science.

[68]  J. Ávila,et al.  Variations in in vivo phosphorylation at the proline-rich domain of the microtubule-associated protein 2 (MAP2) during rat brain development. , 1995, The Biochemical journal.

[69]  J. Ávila,et al.  Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. , 1994, Brain research. Molecular brain research.

[70]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[71]  J. Ávila,et al.  Role of phosphorylated MAPIB in neuritogenesis , 1994 .

[72]  D. Platt,et al.  Dynamics of gene expression for microtubule-associated protein MAP1B, embryonic α-tubulin and late neural β-tubulin mRNAs in the hippocampus of aged rats , 1992 .

[73]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[74]  J. Denny MAP5 in cultured hippocampal neurons: Expression diminishes with time and growth cones are not immunostained , 1991, Journal of neurocytology.

[75]  M. Hasegawa,et al.  Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease , 1990, Neuron.

[76]  R. Vallee,et al.  MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[77]  A. Matus,et al.  Developmental regulation of two microtubule-associated proteins (MAP2 and MAP5) in the embryonic avian retina. , 1987, Development.

[78]  G. Bloom,et al.  Microtubule-associated protein 1B: identification of a major component of the neuronal cytoskeleton. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[79]  R. Morris Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[80]  B. Teter,et al.  Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. , 2006, Journal of Neuroscience Research.

[81]  J. Ávila,et al.  Altered levels of microtubule proteins in brains of Alzheimer's disease patients , 2004, Acta Neuropathologica.

[82]  R. Rissman,et al.  Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology. , 2003, Neuroscience.

[83]  T. Shirao,et al.  Disappearance of actin‐binding protein, drebrin, from hippocampal synapses in alzheimer's disease , 1996, Journal of neuroscience research.

[84]  J. Ávila,et al.  Role of phosphorylated MAPlB in neuritogenesis. , 1994, Cell biology international.

[85]  D. Platt,et al.  Dynamics of gene expression for microtubule-associated protein MAP1B, embryonic alpha-tubulin and late neural beta-tubulin mRNAs in the hippocampus of aged rats. , 1992, Biochemical and Biophysical Research Communications - BBRC.

[86]  S. Young,et al.  Neuronal Fibrillar Cytoskeleton and Endomembrane System Organization in Alzheimer’s Disease , 1987 .